---
id: 093
title: Malaria Species and Treatment
category: clinical_syndromes
subcategory: malaria
tags: [malaria, Plasmodium, chloroquine, artemisinin, atovaquone-proguanil, primaquine]
difficulty: medium
---

## Question

How is malaria treated by species? Use the **"Chloroquine if Sensitive, Artemisinin if Resistant, Primaquine for Hypnozoites"** framework.

## Answer

### **"5 Species, 2 Hypnozoites" Framework:**

**5 Human Malaria Species:**
1. ***P. falciparum*** - **Most severe** (cerebral malaria, high parasitemia)
2. ***P. vivax*** - **Relapsing** (hypnozoites in liver)
3. ***P. ovale*** - **Relapsing** (hypnozoites in liver)
4. ***P. malariae*** - Chronic, low parasitemia
5. ***P. knowlesi*** - Zoonotic (monkeys), severe

**Hypnozoite formers:** *P. vivax* and *P. ovale* (require **primaquine** for cure)

### **Treatment by Species:**

| Species | Chloroquine-Sensitive | Chloroquine-Resistant |
|---------|----------------------|----------------------|
| ***P. falciparum*** | **Chloroquine** 600mg base, then 300mg at 6h, 24h, 48h | **Artemisinin-based therapy:** Artemether-lumefantrine (Coartem) × 3 days OR **Atovaquone-proguanil** (Malarone) 4 tabs daily × 3 days |
| ***P. vivax/ovale*** | **Chloroquine** (as above) **+ Primaquine** 30mg daily × 14 days | **Atovaquone-proguanil** OR **Artemether-lumefantrine** **+ Primaquine** |
| ***P. malariae*** | **Chloroquine** | Rare resistance |
| ***P. knowlesi*** | **Chloroquine** OR **Artemisinin** if severe | — |

### **Severe Malaria (Any Species):**
- **IV Artesunate** (preferred) 2.4 mg/kg at 0, 12, 24h, then daily × 3 days
- Alternative: **Quinidine** (requires cardiac monitoring) + doxycycline/clindamycin

## Key Points

### **Geographic Resistance Patterns:**
- **Chloroquine-resistant *P. falciparum*:** Most of Africa, South America, Southeast Asia
- **Chloroquine-sensitive:** Central America, Caribbean, Middle East
- **Artemisinin resistance:** Emerging in Southeast Asia (Cambodia, Thailand)

### **Primaquine Considerations:**
- **Required** for *P. vivax/ovale* (eradicates hypnozoites, prevents relapse)
- **Contraindicated** in G6PD deficiency (causes hemolysis)
- **Must check G6PD** before giving primaquine
- Alternative: **Tafenoquine** 300mg × 1 dose (if G6PD normal)

### **Clinical Pearls:**
- ***P. falciparum*:** Most severe, no relapse
- ***P. vivax/ovale*:** Relapsing (hypnozoites) → require primaquine
- **Check G6PD** before primaquine
- **Artemisinin-based therapy** preferred for resistant *P. falciparum*
- **IV artesunate** for severe malaria (any species)

## Sources

- [CDC: Malaria Treatment Guidelines 2024]
- [WHO: Guidelines for Malaria Treatment 2024]

## Media

N/A
